Cipla remains in focus after analysts revised their target price downward, citing short-term supply challenges affecting key products. The revision reflects cautious near-term expectations.
Cipla remains in focus after analysts revised their target price downward, citing short-term supply challenges affecting key products. The revision reflects cautious near-term expectations.
Volatility in Indian markets has increased significantly, with investors shifting towards safer assets amid uncertainty. The ongoing geopolitical situation has led to nervousness across global markets.
Indian stock markets opened sharply lower today, with the Sensex falling over 800 points and the Nifty slipping below the 23,100 level. The decline was driven by rising geopolitical tensions between the US and Iran, which impacted global sentiment.
Crude oil prices have surged again due to supply concerns linked to Middle East tensions. This rise is adding pressure on global and Indian equity markets.
UBS on Pharma
Generic GLP-1 likely a highly competitive market; assume sector coverage
Sun Pharma – (Buy) – Looks well-positioned, with innovative medicines and a robust pipeline to support earnings
Cipla – (Neutral) – To face near-term lanreotide supply disruptions, but product launches from late FY27E are healthy
NIFTY OUTLOOK: 223306.45 FII -1805.37 cr DII 5429.78 cr
As discussed yesterday market behaviour remained on the expected lines during the day, as diminishing selling pressure and interruption to present bearish trend help the bulls to take the nifty rally upto 23465.35.
IPO dreams sold at the top: Physicswalla 50% down. Olaelectric 85% down. Firstcry 71% down. Swiggy 52% down. Meesho 43% down & many 100+ IPOs now in huge down.
The National Stock Exchange (NSE) is expected to launch its long-awaited IPO, which has been in discussion for several years. The listing is likely to generate significant investor interest.
PhonePe is preparing for its IPO, aiming to tap into growing investor interest in India’s fintech sector. The company is targeting a multi-billion-dollar valuation for its listing.
Reliance Jio’s upcoming IPO is expected to be one of the biggest listings in India, potentially raising billions of dollars. The offering has already generated strong interest among global investors.
For those of you who are serious about having more, doing more, giving more and being more, success is achievable with some understanding of what to do.
